Page 21 - Pharmaceutical

Strides Shasun to divest UK arm for Rs 240 crore

Shasun Pharma Solutions Ltd (SPSL), which is into CRAMS API business, will be bought by the current management team of SPSL

Strides Shasun's Australian arm inks supply pact with Pharmacy Alliance

The new agreement also includes investment by Arrow Pharmaceuticals, Strides Shasun's Australian subsidiary, in Pharmacy Alliance's plans for growth and retail innovation

Aurobindo Pharma receives US FDA nod for hydromorphone tablet

Hydromorphone hydrochloride tablet, used to relieve moderate to severe pain, has an estimated market size of $ 50 mn for the twelve months ending March 2016, according to IMS

Mylan acquires Renaissance's dermatology biz for $ 1 bn

With this acquisition, the company will have critical mass in the dermatology/topicals area and catapult to a leading position in this space, says Rajiv Malik, president, Mylan

Pfizer to buy biopharma firm Anacor for $ 5.2 bn

Anacor will be a strong fit with Pfizer's innovative business, further supporting its strategic focus on inflammation and immunology

AMRI buys Italian API maker Euticals for $ 358 mn

The deal positions AMRI as one of the largest independent developers and suppliers of API to the pharmaceutical industry